Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12543879rdf:typepubmed:Citationlld:pubmed
pubmed-article:12543879lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:12543879lifeskim:mentionsumls-concept:C0011881lld:lifeskim
pubmed-article:12543879lifeskim:mentionsumls-concept:C0360714lld:lifeskim
pubmed-article:12543879lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12543879pubmed:issue2lld:pubmed
pubmed-article:12543879pubmed:dateCreated2003-1-24lld:pubmed
pubmed-article:12543879pubmed:abstractTextAn inflammatory process may be one of the critical factors that contribute to the development of diabetic nephropathy (DN). We reported previously that intercellular adhesion molecule-1 (ICAM-1) is up-regulated and promotes macrophage infiltration in the glomeruli of diabetic rats. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have recently been emphasized to have anti-inflammatory effects; inhibition of leukocyte adhesion and migration, independent of the cholesterol-lowering effect. The present study was designed to test the hypothesis that statins prevent the development of DN by pleiotropic effects.lld:pubmed
pubmed-article:12543879pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:languageenglld:pubmed
pubmed-article:12543879pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:citationSubsetIMlld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543879pubmed:statusMEDLINElld:pubmed
pubmed-article:12543879pubmed:monthFeblld:pubmed
pubmed-article:12543879pubmed:issn0931-0509lld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:WildD JDJlld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:MakinoHirofum...lld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:YamashitaTets...lld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:HidaKazuyukiKlld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:ShikataKenich...lld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:OkadaShinichi...lld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:MatsudaMitsuh...lld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:OgawaDaisukeDlld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:SatohMinoruMlld:pubmed
pubmed-article:12543879pubmed:authorpubmed-author:UsuiHitomiHlld:pubmed
pubmed-article:12543879pubmed:issnTypePrintlld:pubmed
pubmed-article:12543879pubmed:volume18lld:pubmed
pubmed-article:12543879pubmed:ownerNLMlld:pubmed
pubmed-article:12543879pubmed:authorsCompleteYlld:pubmed
pubmed-article:12543879pubmed:pagination265-72lld:pubmed
pubmed-article:12543879pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:meshHeadingpubmed-meshheading:12543879...lld:pubmed
pubmed-article:12543879pubmed:year2003lld:pubmed
pubmed-article:12543879pubmed:articleTitleHMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats.lld:pubmed
pubmed-article:12543879pubmed:affiliationDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.lld:pubmed
pubmed-article:12543879pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12543879pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12543879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12543879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12543879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12543879lld:pubmed